Litigation

Justices Skeptical About Patent Covering “Millions and Millions of Antibodies”

During arguments in Amgen Inc. v. Sanofi in late March, U.S. Supreme Court Justices expressed concern about the breadth of […]

Michael J. McCarthy, a former assistant DA in Manhattan now with the Kendall Brill & Kelly firm, anticipates two upcoming […]

Decades ago the antitrust plaintiff bar was targeting what was then called “aftermarket restrictions,” explains a post from law firm […]

Last month the Supreme Court heard oral arguments in Jack Daniel’s Properties Inc. v. VIP Products, a dispute that could […]

A securities lawsuit targeting Stanley Black & Decker, a U.S.-based tool manufacturer said to be worth more than $11 billion, […]

There have been several horrifically bad predictions throughout time. In 1903, a bank president predicted to a Ford Motor Company […]

The Illinois Supreme Court recently issued a decision in Cothron v. White Castle System, Inc. which could have significant implications […]

Two upcoming decisions will likely weaken some of the favored tools in a federal prosecutor’s toolbelt. In Ciminelli v. United […]

Zoll Medical, a subsidiary of the Japanese firm Asahi Kasei Group, is facing a minimum of seven putative class actions […]

This could be a decisive year for the federal False Claims Act, with a case about the key issue of […]